SGK1 and metabolic dysfunction-associated steatotic liver disease: Furthermore, recent transcriptomic analyses have identified SGK1 as a crucial node in the PI3K-AKT signaling axis, linking it to both insulin resistance and MASLD pathogenesis [41].